Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages
暂无分享,去创建一个
Gwo-Bin Lee | Chen-Sheng Yeh | Huan-Yao Lei | Gwo-Bin Lee | H. Lei | C. Yeh | Chiau-Yuang Tsai | Shiou-Ling Lu | Chiau-Yuang Tsai | Shiou-Ling Lu | Chia-Wen Hu | Chia-Wen Hu
[1] Haichao Wang,et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. , 2007, Blood.
[2] R. Shukla,et al. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[3] Shaojun Dong,et al. Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV-visible, and infrared spectroscopy. , 2005, Biomacromolecules.
[4] Jin Hong,et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. , 2010, Toxicology and applied pharmacology.
[5] K. Miyake,et al. Cathepsins are required for Toll-like receptor 9 responses. , 2008, Biochemical and biophysical research communications.
[6] Håkan Wallin,et al. Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[7] D. Pozo,et al. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. , 2008, Nanomedicine.
[8] Chao-Liang Wu,et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. , 2007, Molecular pharmaceutics.
[9] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[10] K. Ishii,et al. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. , 2004, Seminars in immunology.
[11] S. Akira,et al. TLR signaling. , 2006, Current topics in microbiology and immunology.
[12] B. Monks,et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.
[13] Y. Yoshioka,et al. Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. , 2010, Biochemical and biophysical research communications.
[14] S. Akira,et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.
[15] Steven A. Curley,et al. Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles , 2010, Clinical Cancer Research.
[16] D. Astruc,et al. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.
[17] A. Iwasaki,et al. Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.
[18] S. Akira,et al. Pathogen recognition in the innate immune response. , 2009, The Biochemical journal.
[19] P. Alivisatos. The use of nanocrystals in biological detection , 2004, Nature Biotechnology.
[20] Moonjung Choi,et al. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. , 2010, ACS nano.
[21] H. Rauvala,et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, Journal of Biological Chemistry.
[22] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[23] David Leong,et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. , 2007, Molecular pharmaceutics.
[24] Nastassja A. Lewinski,et al. Cytotoxicity of nanoparticles. , 2008, Small.
[25] T. Guilarte,et al. Silica-Based Nanoparticle Uptake and Cellular Response by Primary Microglia , 2009, Environmental health perspectives.
[26] H. Ploegh,et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 , 2008, Nature Immunology.
[27] Helinor J Johnston,et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.
[28] Priyabrata Mukherjee,et al. Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.
[29] Andrew E. Parker,et al. Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.
[30] C. Leifer,et al. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA , 2008, Immunology and cell biology.
[31] S. Maschalidi,et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. , 2009, Immunity.
[32] Jürgen Groll,et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. , 2010, ACS nano.
[33] L. Audoly,et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.
[34] Hoguen Kim,et al. Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function. , 2010, Journal of proteome research.
[35] Elodie Boisselier,et al. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.
[36] J. Blenis,et al. ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.
[37] A. Barrios,et al. Inhibition of lysosomal cysteine proteases by chrysotherapeutic compounds: a possible mechanism for the antiarthritic activity of Au(I). , 2004, Bioorganic & medicinal chemistry letters.
[38] Soo-Ki Kim,et al. Dependence on p38 MAPK signalling in the up‐regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis‐treated HeLa cells , 2006, Immunology.
[39] Dar-Bin Shieh,et al. A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity , 2004 .
[40] Chao-Liang Wu,et al. Amelioration of collagen-induced arthritis in rats by nanogold. , 2007, Arthritis and rheumatism.
[41] Ling Wang,et al. Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.
[42] S. Akira,et al. Toll‐like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines , 2003, European journal of immunology.
[43] M. Kretzler,et al. Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] M. James,et al. Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S , 2007, Biological chemistry.
[45] K. Hua,et al. Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression. , 2010, Journal of agricultural and food chemistry.
[46] Håkan Wallin,et al. Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.
[47] G. Frens. Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .
[48] B. Monks,et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.
[49] Siamon Gordon,et al. Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.
[50] Diana Boraschi,et al. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. , 2004, European cytokine network.
[51] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[52] Sarah E. Ewald,et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor , 2008, Nature.
[53] Ji-Ho Park,et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. , 2009, Biomaterials.
[54] O. Schmid,et al. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.